Triplet therapy with venetoclax, FLT3 inhibitor and decitabine for FLT3-mutated acute myeloid leukemia.

ABSTRACT:

SUBMITTER: Maiti A 

PROVIDER: S-EPMC7873265 | biostudies-literature | 2021 Feb

REPOSITORIES: biostudies-literature